Cite
Janus kinase inhibitor for multicentric reticulohistiocytosis, a new potential treatment.
MLA
Li, Yuan, et al. “Janus Kinase Inhibitor for Multicentric Reticulohistiocytosis, a New Potential Treatment.” International Journal of Rheumatic Diseases, vol. 26, no. 9, Sept. 2023, pp. 1656–59. EBSCOhost, https://doi.org/10.1111/1756-185X.14793.
APA
Li, Y., Yin, H., Zhang, L., & Lu, L. (2023). Janus kinase inhibitor for multicentric reticulohistiocytosis, a new potential treatment. International Journal of Rheumatic Diseases, 26(9), 1656–1659. https://doi.org/10.1111/1756-185X.14793
Chicago
Li, Yuan, Hanlin Yin, Le Zhang, and Liangjing Lu. 2023. “Janus Kinase Inhibitor for Multicentric Reticulohistiocytosis, a New Potential Treatment.” International Journal of Rheumatic Diseases 26 (9): 1656–59. doi:10.1111/1756-185X.14793.